Hepatitis C Elimination in the Netherlands (CELINE): How nationwide retrieval of lost to follow-up hepatitis C patients contributes to micro-elimination

Publication date

2022-07

Authors

Isfordink, C J
van Dijk, Marleen
Brakenhoff, Sylvia M.
Kracht, P. A M
Arends, Joop E.ISNI 000000039100595X
de Knegt, Robert J.
van der Valk, Marc
Drenth, Joost P.H.

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by

Abstract

Background & Aims: The number of chronic hepatitis C virus (HCV)-infected patients who have been lost to follow-up (LTFU) is high and threatens HCV elimination. Micro-elimination focusing on the LTFU population is a promising strategy for low-endemic countries like the Netherlands (HCV prevalence 0.16%). We therefore initiated a nationwide retrieval project in the Netherlands targeting LTFU HCV patients. Methods: LTFU HCV-infected patients were identified using laboratory and patient records. Subsequently, the Municipal Personal Records database was queried to identify individuals eligible for retrieval, defined as being alive and with a known address in the Netherlands. These individuals were invited for re-evaluation. The primary endpoint was the number of patients successfully re-linked to care. Results: Retrieval was implemented in 45 sites in the Netherlands. Of 20,183 ever-diagnosed patients, 13,198 (65%) were known to be cured or still in care and 1,537 (8%) were LTFU and eligible for retrieval. Contact was established with 888/1,537 (58%) invited individuals; 369 (24%) had received prior successful treatment elsewhere, 131 (9%) refused re-evaluation and 251 (16%) were referred for re-evaluation. Finally, 219 (14%) were re-evaluated, of whom 172 (79%) approved additional data collection. HCV-RNA was positive in 143/172 (83%), of whom 38/143 (27%) had advanced fibrosis or cirrhosis and 123/143 (86%) commenced antiviral treatment. Conclusion: Our nationwide micro-elimination strategy accurately mapped the ever-diagnosed HCV population in the Netherlands and indicates that 27% of LTFU HCV-infected patients re-linked to care have advanced fibrosis or cirrhosis. This emphasizes the potential value of systematic retrieval for HCV elimination.

Keywords

Linkage to care, Micro-elimination, People who inject drugs, Viral hepatitis, Lost to Follow-Up, Hepacivirus/genetics, Antiviral Agents/therapeutic use, Hepatitis C/epidemiology, Humans, Liver Cirrhosis/drug therapy, Hepatitis C, Chronic/drug therapy, Netherlands/epidemiology, Internal Medicine, Journal Article

Citation

Isfordink, C J, van Dijk, M, Brakenhoff, S M, Kracht, P A M, Arends, J E, de Knegt, R J, van der Valk, M & Drenth, J P H 2022, 'Hepatitis C Elimination in the Netherlands (CELINE) : How nationwide retrieval of lost to follow-up hepatitis C patients contributes to micro-elimination', European Journal of Internal Medicine, vol. 101, pp. 93-97. https://doi.org/10.1016/j.ejim.2022.04.024